Genzyme Manufacturing Issues
Nov. 3, 2024
Genzyme to Give Up $175M in Profits under Consent Decree to Rectify Issues at Production Plant Genzyme flops at FDA – Boston Herald Genzyme Shuts Down Plant Tainted by Virus - WSJ Genzyme Manufacturing Expansion - Pharmaceutical Technology FDA issues warning on Genzyme facility – Boston Herald Genzyme Says FDA Plans Enforcement Action - WSJ | Genzyme Manufacturing Issues
